Casey Woodring
Stock Analyst at JP Morgan
(0.39)
# 4,113
Out of 4,959 analysts
34
Total ratings
23.08%
Success rate
-12.6%
Average return
Main Sectors:
Stocks Rated by Casey Woodring
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRL Charles River Laboratories International | Maintains: Neutral | $145 → $160 | $161.84 | -1.14% | 8 | Aug 7, 2025 | |
| ICLR ICON Public Limited Company | Downgrades: Neutral | $265 → $150 | $175.83 | -14.69% | 6 | Apr 29, 2025 | |
| QDEL QuidelOrtho | Maintains: Underweight | $38 → $25 | $27.90 | -10.39% | 4 | Apr 21, 2025 | |
| HOLX Hologic | Maintains: Overweight | $92 → $94 | $68.26 | +37.71% | 5 | Nov 5, 2024 | |
| QGEN Qiagen | Maintains: Overweight | $54 → $56 | $49.74 | +11.82% | 4 | Jun 18, 2024 | |
| OSUR OraSure Technologies | Maintains: Neutral | $7 → $6 | $3.00 | +100.33% | 3 | May 13, 2024 | |
| EGBN Eagle Bancorp | Maintains: Neutral | $25 → $23 | $19.15 | +20.10% | 2 | Oct 31, 2023 | |
| SHC Sotera Health Company | Upgrades: Neutral | $6 → $18 | $16.43 | +9.56% | 2 | Jan 23, 2023 |
Charles River Laboratories International
Aug 7, 2025
Maintains: Neutral
Price Target: $145 → $160
Current: $161.84
Upside: -1.14%
ICON Public Limited Company
Apr 29, 2025
Downgrades: Neutral
Price Target: $265 → $150
Current: $175.83
Upside: -14.69%
QuidelOrtho
Apr 21, 2025
Maintains: Underweight
Price Target: $38 → $25
Current: $27.90
Upside: -10.39%
Hologic
Nov 5, 2024
Maintains: Overweight
Price Target: $92 → $94
Current: $68.26
Upside: +37.71%
Qiagen
Jun 18, 2024
Maintains: Overweight
Price Target: $54 → $56
Current: $49.74
Upside: +11.82%
OraSure Technologies
May 13, 2024
Maintains: Neutral
Price Target: $7 → $6
Current: $3.00
Upside: +100.33%
Eagle Bancorp
Oct 31, 2023
Maintains: Neutral
Price Target: $25 → $23
Current: $19.15
Upside: +20.10%
Sotera Health Company
Jan 23, 2023
Upgrades: Neutral
Price Target: $6 → $18
Current: $16.43
Upside: +9.56%